The GLP-1 Foundations Score is designed to assess exactly this: not whether youve lost enough weight, but whether the habits underneath are strong enough to maintain it
How GLP-1 Lowers Inflammation in the Body Although originally approved for diabetes, researchers discovered something important: GLP-1 medications consistently reduce inflammation in fat tissue, the gut, the blood vessels, and even the immune system
These structural changes greatly increase the GLP-1 like peptide's half life (t 1/2 = 1 week) compared to endogenous GLP-1 (t 1/2 = 2 minutes)
Retatrutide, a first-in-class GIP, GLP-1 & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test
Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
These findings are mostly applicable to individuals on metformin-based background therapy, while further trial data are required to determine whether the salutary metabolic effects of tirzepatide translate to long-term cardiovascular benefits
